Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and stronger." ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The fact that Medicare spends so much on 25 drugs — out of the roughly 8,000 medications it covers — shows the importance of ...

The agency will announce the 15 new drugs chosen for Medicare negotiation on Friday morning. The companies that manufacture these drugs will have until Feb. 28 to sign negotiation agreement. Health ...

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

The talks around drugs including Novo Nordisk’s Wegovy, GSK’s Trelegy Ellipta, and Pfizer’s Xtandi will set Medicare prices that go into effect in 2027.

CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...